A nurse is collecting data from a client who is taking sumatriptan. Which of the following reports indicates a therapeutic response to the medication?

A. Hydrochlorothiazide can cause electrolyte imbalances, particularly hypokalemia (low potassium levels), hyponatremia (low sodium levels), and hypomagnesemia (low magnesium levels). Monitoring serum electrolyte levels, including potassium, sodium, and magnesium, is essential to detect and manage any abnormalities that may occur as a result of hydrochlorothiazide therapy.
B. Thyroid levels are not typically affected by hydrochlorothiazide therapy. Therefore, monitoring thyroid levels is not necessary in clients taking hydrochlorothiazide for hypertension.
C. Hydrochlorothiazide is not known to affect coagulation studies such as prothrombin time (PT), activated partial thromboplastin time (aPTT), or international normalized ratio (INR).
D. Hydrochlorothiazide is not typically associated with significant hematologic effects that would necessitate routine monitoring of the complete blood count. Therefore, monitoring CBC is not routinely indicated for clients taking hydrochlorothiazide for hypertension.

A. According to the recommended immunization schedule, the second dose of the MMR vaccine is typically administered at 4 to 6 years of age, before starting school. This booster dose helps ensure long- term immunity against measles, mumps, and rubella.
B. The MMR vaccine is typically administered in two doses: the first dose at 12 to 15 months of age and the second dose at 4 to 6 years of age. There is no need for additional MMR immunizations over the next 2 years if the child receives the recommended doses.
C. While the child may receive additional immunizations at 3 years of age, such as the hepatitis B vaccine, the second dose of the MMR vaccine is typically administered at 4 to 6 years of age, not 3 years.
D. Titer testing is typically not recommended for determining the need for further MMR immunizations in young children. The immunization schedule provides specific recommendations for MMR vaccine doses based on age, rather than individual titers.